Skip to main content
Lippincott Open Access logoLink to Lippincott Open Access
. 2023 Aug 22;37(14):2115–2118. doi: 10.1097/QAD.0000000000003692

Persons with severe mental health conditions should be included as a key population in HIV programmes

Melvyn C Freeman a,b, Milton L Wainberg c, Jean D Slabbert a, Selaelo Mabela a, Gustaaf Wolvaardt a
PMCID: PMC10621635  PMID: 37598396

Introduction

Key populations have been identified in the UNAIDS Global AIDS Strategy 2021–2026 [1] as well as in the recent South African National Strategic Plan for HIV, TB and STIs 2023–2028 (NSP) [2] for special focus, additional resource allocation and directed implementation programmes. Key populations are ‘groups of people who are more likely to be exposed to HIV or to transmit it and whose engagement is critical to a successful HIV response’ [1]. People in key populations also face legal and social barriers related to their behaviours that increase their vulnerability to infection [1]. In most settings, this includes MSM, transgender people, people who inject drugs, sex workers and their clients, people in prisons or other closed institutions and people with HIV. However, UNAIDS states that each country should define the specific populations that are key to their epidemic and response [1]. The current key populations account for 62% of new HIV infections globally [1] and are targeted for differentiated and intensive prevention, HIV testing and treatment resources and services. We show here that people with severe mental health conditions (SMHC) meet all the criteria for inclusion and should hence receive added attention and support.

There is a good reason to limit the number of key populations. Simply put, the broader the inclusion, the greater dilution of attention and resources. We are aware too that other persuasive cases have been made for inclusion [3]. Notwithstanding, we show here that the inclusion of SMHC is fully justified. We use the example of South Africa to illustrate this, however, the ratio of the difference between those with a SMHC living with HIV relative to the general population in lower HIV prevalence regions is generally larger than in high prevalence areas [4], and, therefore, our conclusions cover most countries.

The South African National Strategic Plan for HIV, TB and STIs 2023–2028

Following global trends [5], there has been a substantial shift in understanding and appreciation of the mental health needs of PWH in South Africa. This is well reflected in the recent NSP where people with mental disorders are included as a ‘priority population’ [2]. Although word counts are an imprecise and unscientific method for measuring importance and relevance, the current NSP mentions mental health 146 times, compared with just 12 in the previous one. This is not merely a change in numbers though, close examination shows that mental health is carefully woven into the plan based on available information and a clear commitment to integrating mental health and HIV/TB care. However, the concentration in the NSP is on common mental health conditions such as depression and anxiety, and mental health services for key populations. It does not address people with SMHC as a key group that itself requires prioritization.

Persons with severe mental health conditions

SMHC refer to a wide range of diagnoses that have common psychiatric symptoms, which persist over time and are functionally disabling. Schizophrenia, schizoaffective disorder, other psychotic disorders, bipolar disorder, and major depressive disorder with psychotic features are usually classified as severe [6]. Amongst numerous reasons to focus on this group as a key population, three stand out:

  • 1.

    Persons with SMHC are significantly more likely than the general population to be exposed to risk factors for HIV and, because of behavioural practices, to transmit the virus [7]. In actual numbers, they not only meet the criteria for inclusion but also place a greater risk for the spread of HIV than certain groups already identified as key populations (see Table 1). Due to their mental health status, they also usually receive less HIV prevention and treatment [6].

  • 2.

    Persons with SMHC need highly targeted HIV prevention, treatment, and care programmes. Such interventions have been shown to have proven effectiveness [8].

  • 3.

    Including persons with any mental health condition as a key population has merit; however, it is difficult to establish HIV prevalence in this broad group and also to assess whether the HIV precedes or is a consequence of the mental health condition. Determining the prevalence of HIV in the population of people with SMHC is simpler. Moreover, people with SMHC have unique needs that require differentiated and precise responses.

Table 1.

Key population groups and persons with severe mental health conditions, by percentage living with HIV, proportion of adult population, number in the population, and estimated number living with HIV in that population.

Key population Estimated percentage living with HIV Estimated proportion of the adult (15 plus) population Estimated number of people in the general population. Estimated number living with HIV
Sex workers 57.9% 0.85% of adult female populationa 187 000 108 273
Transgender persons 51.9% 2% of adult populationb 860 000 446 340
MSM 29.9% 10% of adult population (only, mostly or equally attracted to same sex)c 2 150 000 642 850
People who inject drugs 21.8% 0.17% of adult populationd 75 000 16 350
Prison population 17.5% 0.34% of adult populatione 148 000 25 900
People with severe mental health conditions 23% 1.5% of adult population 645 000 148 350
a

Konstant TL, Rangasami J, Stacey MJ, et al. Estimating the number of sex workers in South Africa: rapid population size estimation. AIDS Behav 2015;19 Suppl 1: 3–15.

c

Ipsos | LGBT+ Pride 2021 Global Survey. GBT%20Pride%202021%20Global%20Survey%20Report_3.pdf. [Accessed 27 June 2023].

d

Odendaal L. Low harm reduction coverage for people who inject drugs in South Africa. AIODSMAP https://www.aidsmap.com/news/jul-2019/low-harm-reduction-coverage-people-who-inject-drugs-south-africa. [Accessed 27 June 2023].

e

Fair H, Walmsley R. World Prison Population List thirteenth edition. https://www.prisonstudies.org/sites/default/files/resources/downloads/world_prison_population_list_13th_edition.pdf. [Accessed 26 June 2023].

Meeting the criteria for inclusion as a key population

Risk and vulnerability

Many people with SMHC engage in behaviours that increase their risk of infection, including unprotected sex with multiple partners, sex work and intravenous drug use; engage in hypersexuality during acute phases; have co-occurring substance misuse problems that can lead to sexual risks; live in shared accommodation and in institutions [6] (often same gender) where sexual activity is often not accepted and protection is not provided. Mental health conditions are also associated with lower adherence to HIV treatment [9].

People with SMHC experience both social and legal barriers that put them at greater risk of contracting and spreading HIV.

Social barriers include poor physical healthcare, perceptions that people with SMHC are unable to comprehend sex education, beliefs that people with SMHC are poor adherers to medication and thus not worth providing treatment to [10], stigmatization and discrimination based on mental health status [11], and violence and abuse [12], including sexual abuse.

People with SMHC generally receive far poorer quality physical health interventions [13]. Although people with SMHC have twice as many healthcare contacts, they receive less physical check-ups and screenings, less prescriptions, and have fewer procedures conducted [10]. They die 10–20 years earlier than the general population [13]. The vast majority of these deaths are because of preventable physical diseases, including AIDS. AIDS-related mortality has been found to be high in people with SMHC in South Africa [14].

Legal barriers include commitment to institutions without consent and hence increased risk of HIV. Studies of closed facilities in South Africa have found high rates of HIV [1517]. There are also laws in South Africa that restrict persons of ‘unsound mind’ to access the same social, civil, economic, and political rights as others. Becoming a key population would put such issues under additional human rights scrutiny and increase the likelihood of revision.

Prevalence

Inclusion as a key population requires substantially higher HIV prevalence than the general population. To determine the HIV prevalence rate amongst persons with SMHC in South Africa, PubMed and Google searches were conducted. Five studies published since 2000 were found. Three of these were in-patient and two community-based. HIV prevalence rate ranged from 19 to 29.1% [1519].

Given that existing prevalence studies were not representative of the population, we used the available studies and conservatively estimated prevalence at 23%. The percentage of existing key populations living with HIV was taken from the NSP estimates [2]. We took the number of people with SMHC at 1.5% [20] and the population of South Africa as 60.6 million (adult population, 43 million) [21].

We then compared people with SMHC with the already identified key population groups with respect to prevalence percentages and estimated numbers in each group.

Table 1 shows that the percentage HIV prevalence in persons with SMHC is higher than two of the already identified key populations. In actual numbers, persons with SMHC living with HIV is larger than three of the five already identified groups.

Targeted HIV prevention and care programmes

It is beyond the scope of this opinion piece to outline a full list of specific interventions that persons with SMHC require. However, vital interventions that are sorely needed and are more likely to be rectified if SMHC is added as a KP include the following.

Prevention

Targeted preexposure prophylaxis (PrEP) needs to be expanded for SMHC [6]. Given concerns about adherence in this group, long-acting injectable PrEP may prove highly appropriate to this population. Notwithstanding, people with SMHC must be given the same prevention options and choices as others. Primary prevention efforts such as correct condom use are effective for people with SMHC [8]. However, these skills must be reviewed repeatedly to maintain gains. Postexposure prophylaxis (PEP) may also be important for this group.

Custom key population prevention such as education programmes designed for SMHC are required to curtail HIV infection among this population and their partners. Specially designed and proven key population prevention programmes are easy to administer, feasible, and inexpensive [8].

Testing for and treating HIV

Routine HIV testing of people with SMHC is generally low [6], though essential [7]. Some practitioners and even family members hold the erroneous belief that people with SMHC are not sexually active and hence do not need HIV testing. This applies also in same-sex settings. With respect to treatment, HIV-positive individuals with SMHC have been found to be prescribed antiretroviral therapy (ART) less often than their non-SMHC counterparts [22]. This may be because of the mistaken belief that should a person with a mental health condition be found to be HIV positive that they would not have the capacity to take or adhere to their medication regularly. However, research shows that people with SMHC receiving quality HIV care and additional psychosocial support can achieve adherence rates comparable to those without mental health conditions [23].

Inclusion as a key population is likely to lead to a substantial increase in clear and evidence-based policies as well as support programmes for SMHC. For example, at present, there are no internationally agreed-upon guidelines to support the prevention, screening, and management of people who have both HIV infection and SMHC [6]. Development of such guidelines is probable if included as a key population. Essential interventions that have been proposed over a number of years, such as training of mental health practitioners to test and treat for HIV in persons with SMHC and special support programmes for practitioners, family members and people with lived experience [24], are far more likely to be implemented. Similarly, including mental health in the training of practitioners providing HIV services, such as nurses providing NIMART (Nurse Initiated Management of ART) is likely to increase. WHO and UNAIDS recommendations for the full integration of mental health and HIV services [5] will, in all likelihood, also be fast-tracked.

In conclusion, the case for the inclusion of persons with SMHC as a key population is compelling. That this group has not already been added is likely to be an omission resulting from a dearth of relevant information and data, combined with a lack of concerted advocacy. However, this may also be related to high levels of general discrimination and stigmatization against persons with SMHC [11]. Unfortunately, structural stigma has influenced global and local policies as well as funding to address the needs of people living with mental health conditions.

Self-advocacy by people in the current key population groups has played a critical role in governments and international agencies and organizations focusing on HIV prevention and treatment. People from current key populations have experienced intense stigma and discrimination while fighting to be heard, but they have prevailed and been included for special focus. However, being an advocate while also experiencing a SMHC may well be of a different order, making advocacy even more difficult. Recently, global organizations of peers have been formed that are seriously advocating for the rights of persons with lived experience [25,26], but given past and current neglect of many mental health issues, HIV has not yet been an advocacy priority.

We do not wish to replace this self-advocacy, but we hope that the facts and arguments here are convincing enough to get authorities to carefully consider the inclusion of persons with SMHC as a key population. This is critical to the people involved and for reaching the UNAIDS 95–95–95 targets.

Acknowledgements

All authors jointly agreed to draft an opinion after identifying difficulties with getting attention and resources to people with severe mental health conditions despite this group meeting all the criteria of a key population. M.F. drafted the first version and all authors provided comments that were incorporated. All authors agreed with the final version.

Conflicts of interest

There are no conflicts of interest.

References

  • 1.UNAIDS. Global AIDS strategy 2021–2026 end inequalities. End Aids. Geneva: UNAIDS; 2021. [Google Scholar]
  • 2.South African National AIDS Council. National Strategic Plan for HIV, TB and STIs 2023-2028. Pretoria: South African National AIDS Council; 2023. [Google Scholar]
  • 3.Shisana O, Zungu N, Evans M, Risher K, Rehle T, Clementano D. The case for expanding the definition of ’key populations’ to include high-risk groups in the general population to improve targeted HIV prevention efforts. S Afr med J 2015; 105:664–669. [DOI] [PubMed] [Google Scholar]
  • 4.Remien RH, Stirratt MJ, Nguyen N, Robbins RN, Pala AN, Mellins CA. Mental health and HIV/AIDS: the need for an integrated response. AIDS 2019; 33:1411–1420. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Integration of mental health and HIV interventions. Key considerations. Geneva: Joint United Nations Programme on HIV/AIDS and the World Health Organization; 2022. Licence: CC BY-NC-SA 3.0 IGO. [Google Scholar]
  • 6.McKinnon KM, Alves-Bradford JM, Cournos F. Bourgeois JA, Cohen MA, Makurumidze G. HIV and serious mental illness. Springer, HIV psychiatry. Cham: 2022. [Google Scholar]
  • 7.Meade C, Sikkema K. HIV risk behavior among adults with severe mental illness: a systematic review. Clin Psychol Rev 2005; 25:433–457. [DOI] [PubMed] [Google Scholar]
  • 8.Andriote JM, in collaboration with the APA Commission on AIDS. HIV mental health treatment issues. HIV and people with severe mental illness. [Google Scholar]
  • 9.Remien RH, Patel V, Chibanda D, Abass MA. Integrating mental health into HIV prevention and care: a call to action. J Int AIDS Soc 2021; 24: (Suppl 2): e25748. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Hobkirk AL, Towe SL, Lion R, et al. Primary and secondary HIV prevention among persons with severe mental illness: recent findings. Curr HIV/AIDS Rep 2015; 12:406–412. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Thornicroft G, Sunkel C, Alikhon Aliev A, Baker S, Brohan E, El Chammay R, et al. The Lancet Commission on ending stigma and discrimination in mental health. Lancet 2022; 22:1438–1480. [DOI] [PubMed] [Google Scholar]
  • 12.Desmarais SL, Van Dorn RA, Johnson KL, Grimm KJ, Douglas KS, Swartz MS. Community violence perpetration and victimization among adults with mental illnesses. Am J Public Health 2014; 104:2342–2349. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Liu NH, Daumit GL, Dua T, Aquila R, Charlson F, Cuijpers P, et al. Excess mortality in persons with severe mental disorders: a multilevel intervention framework and priorities for clinical practice, policy and research agendas. World Psychiatry 2017; 16:30–40. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Haas AD, Ruffieux Y, van den Heuvel LL, Lund C, Boulle A, Euvrard J, et al. IeDEA Southern Africa collaboration. Excess mortality associated with mental illness in people living with HIV in Cape Town, South Africa: a cohort study using linked electronic health records. Lancet Glob Health 2020; 8:e1326–e1334. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Mwelase MP, Ntlantsana V, Tomita A, Chiliza B, Paruk S. HIV prevalence and access to HIV testing and care in patients with psychosis in South Africa. S Afr J Psychiatr 2023; 29:1918. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Collins P, Berkman A, Mestry K, Pillai A. HIV prevalence among men and women admitted to a South African public psychiatric hospital. AIDS Care 2009; 21:863–867. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Singh D, Berkman A, Bresnahan M. Seroprevalence and HIV-associated factors among adults with severe mental illness – a vulnerable population. SA J Psych 2009; 99:523–527. [PMC free article] [PubMed] [Google Scholar]
  • 18.Aboobaker A, Zingela Z, Adeniyi OV. Correlates and cascade of HIV care in patients with psychiatric disorders in the Eastern Cape Province, South Africa. SAJP 2022; 28:1753. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Mokgatle M. Self-reported prevalence of HIV infection, sexually transmitted infections and risky sexual behavior among mental healthcare users accessing healthcare services in Tshwane district, South Africa. Healthcare (Basel) 2021; 9:1398. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.World Health Organization. World Mental Health Report: transforming mental health for all. Geneva: World Health Organization; 2022. [Google Scholar]
  • 21. Statistics SA. Available at: https://www.statssa.gov.za/?p=15601. [Accessed 27 June 2023] [Google Scholar]
  • 22.McGinty EE, Baller J, Azrin ST, Juliano-Bult D, Daumit GL. Quality of medical care for persons with serious mental illness: a comprehensive review. Schizophr Res 2015; 165:227–235. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Himelhoch S, Brown CH, Walkup J, Chander G, Korthius PT, Afful J, Gebo KA. HIV patients with psychiatric disorders are less likely to discontinue HAART. AIDS 2009; 23:1735–1742. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Blank MB, Himelhoch S, Walkup J, Eisenberg MM. Treatment considerations for HIV-infected individuals with severe mental illness. Curr HIV/AIDS Rep 2013; 10:371–379. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25. The Global Mental Health Peer Network. Available at: https://www.gmhpn.org/contact-us.html. [Accessed 5 May 2023] [Google Scholar]
  • 26. World Network of Users and Survivors of Psychiatry. Available at: http://wnusp.net/index.php/wnusp-contact-information.html. [Accessed 5 May 2023] [Google Scholar]

Articles from AIDS (London, England) are provided here courtesy of Wolters Kluwer Health

RESOURCES